Answers are grounded in this paper and cite their sources.
In vitro study reveals active compounds in Buyang Huanwu decoction enhance neural repair markers in injured PC12 cells, indicating mechanisms for axonal regeneration.
Buyang Huanwu decoction (BHD), a popular formulation prescribed in traditional Chinese medicine (TCM) for the treatment of ischemic stroke, has been reported to have a potential role in promoting axonal regeneration. The purpose of the study was to screen and identify bioactive compounds from BHD using live PC12 cells coupled with high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Using this approach, we successfully identified six bioactive components from BHD. These components have protective effects on oxygen-glucose deprivation/reperfusion (OGD/R) injury to PC12 cells. Furthermore, calycosin-7- D -glucoside (CG) and formononetin-7-O- β - D -glucoside (FG) could upregulate the protein expression of growth-associated protein 43 (GAP-43) and brain-derived neurotrophic factor (BDNF). This study suggests that living cells combined with HPLC-MS/MS can be used for the screening of active ingredients in TCMs.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: